A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer
eLife · 18.12.2024 · 12
DOI: 10.7554/elife.87369 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 18.12.2024. Verfasst von Bruno Bockorny und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Tumor, Pancreatic Neoplasms, Proteomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, UM1, NIH HHS.
Abstract (Originalsprache)
Pancreatic cancer has the worst prognosis of all common tumors. Earlier cancer diagnosis could increase survival rates and better assessment of metastatic disease could improve patient care. As such, there is an urgent need to develop biomarkers to diagnose this deadly malignancy. Analyzing circulating extracellular vesicles (cEVs) using ‘liquid biopsies’ offers an attractive approach to diagnose and monitor disease status. However, it is important to differentiate EV-associated proteins enriched in patients with pancreatic ductal adenocarcinoma (PDAC) from those with benign pancreatic diseases such as chronic pancreatitis and intraductal papillary mucinous neoplasm (IPMN). To meet this need, we combined the novel EVtrap method for highly efficient isolation of EVs from plasma and conducted proteomics analysis of samples from 124 individuals, including patients with PDAC, benign pancreatic diseases and controls. On average, 912 EV proteins were identified per 100 µL of plasma. EVs containing high levels of PDCD6IP, SERPINA12, and RUVBL2 were associated with PDAC compared to the benign diseases in both discovery and validation cohorts. EVs with PSMB4, RUVBL2, and ANKAR were associated with metastasis, and those with CRP, RALB, and CD55 correlated with poor clinical prognosis. Finally, we validated a seven EV protein PDAC signature against a background of benign pancreatic diseases that yielded an 89% prediction accuracy for the diagnosis of PDAC. To our knowledge, our study represents the largest proteomics profiling of circulating EVs ever conducted in pancreatic cancer and provides a valuable open-source atlas to the scientific community with a comprehensive catalogue of novel cEVs that may assist in the development of biomarkers and improve the outcomes of patients with PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States.
- Harvard Medical School, Boston, United States.
- Blueprint Medicines, Cambridge, United States.
- Henry Ford Cancer Institute, Detroit, United States.
- Department of Biochemistry, Purdue University West Lafayette, West Lafayette, United States.
- Nanyang Technological University, Singapore, Singapore.
ORCID-Profile: Bruno Bockorny, Ling Huang, Weiguo Andy Tao, Anton Iliuk, Senthil K Muthuswamy
Förderung
- NCI NIH HHS
- UM1
- NIH HHS
- Institutional startup funds, Beth Israel Deaconess Medical Center
- Hirshberg Foundation
- National Institutes of Health
Zitieren
APA
Bockorny, B., Muthuswamy, L., Huang, L., Hadisurya, M., Maria Lim, C., Tsai, L. L., Gill, R. R., Wei, J. L., Bullock, A. J., Grossman, J. E., Besaw, R. J., Narasimhan, S., Tao, W. A., Perea, S., Sawhney, M. S., Freedman, S. D., Hildago, M., Iliuk, A., & Muthuswamy, S. K. (2024). A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. eLife, 12. https://doi.org/10.7554/elife.87369
Vancouver
Bockorny B, Muthuswamy L, Huang L, Hadisurya M, Maria Lim C, Tsai LL, et al. A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. eLife. 2024;12. doi:10.7554/elife.87369
BibTeX
@article{Bockorny2024,
author = {Bockorny, Bruno and Muthuswamy, Lakshmi and Huang, Ling and Hadisurya, Marco and Maria Lim, Christine and Tsai, Leo L and Gill, Ritu R and Wei, Jesse L and Bullock, Andrea J and Grossman, Joseph E and Besaw, Robert J and Narasimhan, Supraja and Tao, Weiguo Andy and Perea, Sofia and Sawhney, Mandeep S and Freedman, Steven D and Hildago, Manuel and Iliuk, Anton and Muthuswamy, Senthil K},
title = {A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer},
journal = {eLife},
year = {2024},
volume = {12},
doi = {10.7554/elife.87369}
}
EUVIMED